Status:
COMPLETED
Concealment of Chemotherapy Drug Serum With a Picture Box Effect on Anxiety, Nausea and Vomiting in Children
Lead Sponsor:
Maltepe University
Conditions:
Nursing Caries
Art Therapy
Eligibility:
All Genders
5-10 years
Phase:
NA
Brief Summary
The aim of this study was to present the results of the effect of concealing chemotherapy drug serum with a picture box on children's anxiety, nausea and vomiting. The study was planned with children ...
Detailed Description
Childhood cancers require intensive health care and have a high burden of disease. Childhood cancers have turned into a chronic disease that causes increasing physical and psychosocial symptoms all ov...
Eligibility Criteria
Inclusion
- 5-10 years old (The scale used is between this age group, these children should be willing to draw and should be suitable for their developmental periods)
- Inpatients with cancer,
- Those receiving the second and subsequent courses of chemotherapy,
- Previous chemotherapy experience,
- Those receiving chemotherapy drugs, the duration of chemotherapy lasting an average of 1 to 6 hours
- Those taking chemotherapy drugs with minimal, low and moderate severity of nausea and vomiting,
- Children whose parents agreed to participate in the study were included in the study.
Exclusion
- Those in the last stage of cancer (experiencing the side effects of treatment intensively during hospitalisation due to the disease and symptoms causing complications)
- Those receiving oral chemotherapy,
- Those who experience intense side effects of chemotherapy (febrile neutropenia, bleeding, allergic reactions),
- People with mental problems (depression, anxiety disorders, disruptive behaviour disorders, neurodevelopmental disorders),
- People on antidepressant medication,
- Those who have a physical disability (e.g. amputation, lack/inability to use arms, hands and fingers, visual or hearing impairment, etc.) to paint during chemotherapy, and
- Children taking medicines with high severity of nausea and vomiting were not included in the study.
Key Trial Info
Start Date :
October 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06999759
Start Date
October 3 2024
End Date
May 5 2025
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara Unıvesıty Educatıon And Research Hospıtal Istanbul, Pendik, Turkey, 34000 .
Istanbul, Turkey (Türkiye), 34000